If You Were Advising Hoffmann-LaRoche, Which Set Up Roche Partnering

If you were advising Hoffmann-LaRoche, which set up Roche Partnering to manage more than 190 alliances in the healthcare industry, what might not be a reason why some of those alliances could prove to be unstable or break apart?

A) Anticipated gains may fail to materialize for Roche Partnering due to an overly optimistic view of the synergies.
B) Anticipated gains for Roche Partnering may fail to materialize due to a poor fit in terms of the combination of resources and capabilities.
C) One or more of the 190 partners in Roche Partnering could gain access to another company's proprietary knowledge base, technologies, or trade secrets.
D) The partners may disagree among themselves over how to divide the profits gained from joint collaboration.
E) There is a risk for any or all of the 190 partners in Roche Partnering to become overly dependent on other companies within the partnership.